Related references
Note: Only part of the references are listed.Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
Rachael M. Zemek et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Anna E. Vilgelm et al.
FRONTIERS IN IMMUNOLOGY (2019)
NKp46 Receptor-Mediated Interferon-gamma Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
Ariella Glasner et al.
IMMUNITY (2018)
Targeting Toll-Like Receptors for Cancer Therapy
Marc J. Braunstein et al.
TARGETED ONCOLOGY (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A. Trujillo et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Not All Immune Checkpoints Are Created Equal
Annika De Sousa Linhares et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella
Y. Hiriart et al.
PROTEIN SCIENCE (2017)
Combination of immune checkpoint inhibitors and radiotherapy: Review of the literature
Alessandro Sindoni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
The rapidly evolving therapies for advanced melanoma-Towards immunotherapy, molecular targeted therapy, and beyond
Ziqiang Zhu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
F. Stephen Hodi et al.
LANCET ONCOLOGY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Melanoma immunotherapy dominates the field
Panagiotis Diamantopoulos et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Immunotherapy: The Path to Win the War on Cancer?
CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
Hyangsoon Noh et al.
CELL COMMUNICATION AND SIGNALING (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors
Sebastian Schoelch et al.
ONCOTARGET (2015)
Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice
Andres H. Rossi et al.
PLOS ONE (2015)
The importance of animal models in tumor immunity and immunotherapy
Sadna Budhu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
TLR agonists for cancer immunotherapy: tipping the balance between the immune stimulatory and inhibitory effects
Hailing Lu
FRONTIERS IN IMMUNOLOGY (2014)
Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
Melissa G. Lechner et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment
Alexander M. Lesokhin et al.
CANCER RESEARCH (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants
Paula M. Berguer et al.
PLOS ONE (2012)
Targeting the tumor mutanome for personalized vaccination therapy
Sebastian Kreiter et al.
ONCOIMMUNOLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
Gerty Schreibelt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
Vesna Pulko et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo
Virginia Andreani et al.
CANCER RESEARCH (2007)
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
W. Scott Webster et al.
JOURNAL OF IMMUNOLOGY (2007)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
Brucella spp. lumazine synthase:: a novel adjuvant and antigen delivery system to effectively induce oral immunity
Gabriela Rosas et al.
MICROBES AND INFECTION (2006)
A polymeric bacterial protein activates dendritic cells via TLR4
PM Bergner et al.
JOURNAL OF IMMUNOLOGY (2006)
Multiple display of a protein domain on a bacterial polymeric scaffold
PO Craig et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides
DA Laplagne et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Divergence in macromolecular assembly:: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus
BC Braden et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
